Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia: The LAPLACE-2 Randomized Clinical Trial

Overview of attention for article published in JAMA: Journal of the American Medical Association, May 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog
policy: 1 policy source
twitter: 27 X users
patent: 4 patents

weibo: 2 weibo users
facebook: 3 Facebook pages
wikipedia: 2 Wikipedia pages
guideline: 4 clinical guideline sources

Readers on

mendeley: 464 Mendeley

So far, Altmetric has seen 12 news stories from 12 outlets.

Nabil Seidah: The Discovery That Led to PCSK9 Therapies

Medscape, 16 Feb 2026

Nabil G. Seidah, PhD Nabil G. Seidah, PhD, an Egyptian Canadian scientist based in Montreal, has spent decades investigating…

'Keep taking statins' says drug body

World News Network, 30 May 2014

People should continue to take statins because the benefits do outweigh the risks, according to fresh advice from the UK's drug…

New Drug May Help Lower 'Bad' Cholesterol Beyond Statins

Medicinenet, 15 May 2014

Title: New Drug May Help Lower 'Bad' Cholesterol Beyond Statins Category: Health News Created: 5/13/2014 4:36:00 PM Last…

New injectable drug further lowers bad cholesterol

Health24, 14 May 2014

Injectable therapy can lower cholesterol even further than statins; the drug helps to lower bad cholesterol levels in the body.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 8 additional news stories.